Katherine Davoli
University of Pittsburgh
8 Papers
19 Citations
Katherine Davoli is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Stem cell & Medicine. The author has an hindex of 4, co-authored 6 publications. Previous affiliations of Katherine Davoli include Oberlin College.
Chat about Author
Papers
Differentiation of human embryonic stem cells into cells with corneal keratocyte phenotype.
Audrey A. Chan,Andrew Hertsenberg,Martha L. Funderburgh,Mary M. Mann,Yiqin Du,Katherine Davoli,Jocelyn D. Mich-Basso,Lei Yang,James L. Funderburgh +8 more
TL;DR: Results show hES cells can be induced to differentiate into keratocytes in vitro, and pluripotent stem cells, therefore, may provide a renewable source of material for development of treatment of corneal stromal opacities.
73
Delaying the Expression of Herpes Simplex Virus Type 1 Glycoprotein B (gB) to a True Late Gene Alters Neurovirulence and Inhibits the gB-CD8+ T-Cell Response in the Trigeminal Ganglion
Srividya Ramachandran,Katherine Davoli,Michael B. Yee,Robert L. Hendricks,Paul R. Kinchington +4 more
TL;DR: A recombinant HSV-1 in which gB is expressed only after viral DNA synthesis from the true late gC promoter (gCp-gB) was created, suggesting that gB-CD8 cells can block HSv-1 reactivation at a very late stage in the viral life cycle.
26
Lac z Histochemistry and immunohistochemistry reveal ephrin-B ligand expression in the inner ear.
TL;DR: Immunostaining in transgenic mice carrying the lac z gene can be used to map gene and protein distribution in a single tissue and indicated which antibody was specific for the transmembrane-bound ephrin-B2 ligand.
13
Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease
Madeline M. Schwarz,Kaleigh Connors,Katherine Davoli,Cynthia M. McMillen,Joseph R. Albe,Ryan M. Hoehl,Matthew Demers,Safder S. Ganaie,David Price,Daisy W. Leung,Gaya K. Amarasinghe,Anita K. McElroy,Douglas S. Reed,Amy L. Hartman +13 more
TL;DR: Evidence is provided of how RVFV infects the eye, and information can be applied to help mitigate the devastating outcomes of RVF ocular disease through vaccines or treatments, providing a foundation for evaluation of vaccines and therapeutics to protect against adverse ocular outcomes.
9